Company news

Argent Biopharma Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Canaccord to Lead LSE Listing and $4.75m Placement Closed

August 21, 2019

MXC 100 Patient Milestone in Aus, Onboards Tetra Health

August 12, 2019

MGC Signs Agreement for Construction of GMP Pharma Facility

August 8, 2019

Additional Information on Ground-breaking Research

July 29, 2019

MGC Research- Effectiveness of Cannabinoids on Brain Cancers

July 23, 2019

Germany, Austria & Switzerland Distribution Agreement Signed

June 21, 2019

Brazil Distribution Agreement signed for MGC Pharma Products

June 19, 2019

Pharma Update - Increased Orders and Clinical Study

June 12, 2019

Material Revenues Confirmed from Non-Pharma Business Units

June 4, 2019

Cultivation Licence Granted by the Office of Drug Control

May 28, 2019

Arrival of First CannEpil Shipment to United Kingdom

May 6, 2019

UK Distribution Agreement with Grow Biotech and IPS

May 5, 2019

New Distribution Agreements Signed for CannEpil & IMPs

May 2, 2019

Agreement for CBD Nutraceuticals Entry into China Market

April 17, 2019

Received CannEpil Purchase Orders and Import Permit for UK

April 11, 2019

MXCs 2019 Pharma Commercialisation Strategy

April 1, 2019

Independent Validation of MXC High-Grade Cannabis Genetics

February 25, 2019

MXC Botanical Update

January 31, 2019

Completion of MGC Derma Sale to CannaGlobal

January 28, 2019

Major Regulatory Milestones Achieved for Pharma Business

January 21, 2019

First CannEpil Product arrives in Australia

December 23, 2018

MGC Derma - CannaGlobal Transaction Update

December 2, 2018

Chairmans Address - 2018 AGM

November 22, 2018

MXC launches CannaHub with RMIT and HUJ

November 18, 2018

Legal Proceedings Commenced against Varm Cosmo

November 14, 2018

Definitive Agreement Signed for Sale of MGC Derma

November 13, 2018

Response to ASX Price and Volume Query

October 16, 2018

CannEpil Authorised to Commence Australian Sales

October 10, 2018

Sale of MGC Derma to Strategic Partner Cannaglobal Canada

September 27, 2018

Contract Default Notice Issued To Varm Cosmo

September 24, 2018

MXC Signs Major Distribution Agreement for GMP Products

September 6, 2018

Appendix 4E and Audited 2018 Financial Report

September 2, 2018

MXC to Commence Australian Dementia Trial with Notre Dame

August 27, 2018

Harvey Nichols Expands MGC Derma Distribution in the UK

August 7, 2018

MXC Awarded GMP Certification & Manufacturing Licence

July 13, 2018

Harvey Nichols To Sell MGC Derma and Derma Plus Cosmetics

June 12, 2018

Maltese Government Approves Medicinal Cannabis Legislation

May 21, 2018

Corporate Update - CEO steps into Managing Director role

May 15, 2018

MGC Derma launches Second Derma Plus CBD Product

May 10, 2018

Malta Govt Approval for MC Licensed Facility

April 12, 2018

$5m Placement at 7.0c Closed Stongly Oversubscribed

April 11, 2018

Contract Secured for Full MC Production Facility in Malta

April 10, 2018

Production of First CannEpil Batch Commences at EU Facility

March 28, 2018

MXC Launches MGC Nutraceuticals Product Line

March 13, 2018

Updated MXC Operational and Strategy Update

March 4, 2018

MXC Derma Products Officially Launched on Cult Beauty Online

February 13, 2018

Initial GMP Certification for European Production Facility

January 24, 2018

MXC Signs Exclusive Distribution Agreement with Cult Beauty

January 21, 2018

MXC Welcomes Federal Export Legislation

January 4, 2018

MGC Derma Launches CBD Herbal Psoriasis Cream

January 3, 2018

← Newer news releases · Older news releases →

Decks

The 5 newest of 10 decks. Every deck is listed under its year.